08/07/2024 Healthcare
SATLIV-300 tablets contain Ursodeoxycholic Acid (UDCA), used to treat gallstones and primary biliary cirrhosis. UDCA works by reducing cholesterol production and dissolving cholesterol-based gallstones, improving bile flow in liver disease. It helps protect liver cells and improve liver function. Dosage and duration should be determined by a healthcare provider to ensure effective treatment and minimize potential side effects in managing gallstone and liver conditions.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
SATLIV-300 tablets contain Ursodeoxycholic Acid (UDCA), used to treat gallstones and primary biliary cirrhosis. UDCA works by reducing cholesterol pro...
Nicopenta 40 Tablet is a medicine that reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stoma...
Satgest SR 300 tablets contain Progesterone in a sustained-release formulation, designed to regulate menstrual cycles and support pregnancy. Used to m...
OLY-XT Tablets contain Ferrous Ascorbate, Folic Acid, and Zinc Sulfate, essential nutrients for treating and preventing anemia. Ferrous Ascorbate prov...
More Details